NCT00981058 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 545
- group Id
- BG001
- value
- 548
- group Id
- BG002
- value
- 1093
- units
- Participants
- groups
- description
- Necitumumab + Gemcitabine + Cisplatin Necitumumab: 800 mg I.V. infusion on Days 1 and 8 of every 3 week cycle. Continues until progressive disease, toxicity, noncompliance, or withdrawal. Gemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle. Continues for a maximum of six cycles. Cisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle. Continues for a maximum of six cycles.
- id
- BG000
- title
- Necitumumab + Gemcitabine + Cisplatin
- description
- Gemcitabine + Cisplatin Gemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle. Continues for a maximum of six cycles. Cisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle. Continues for a maximum of six cycles.
- id
- BG001
- title
- Gemcitabine + Cisplatin
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 32
- upper Limit
- 84
- value
- 62.0
- group Id
- BG001
- lower Limit
- 32
- upper Limit
- 86
- value
- 62.0
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 86
- value
- 62.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 95
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 185
- title
- Female
- measurements
- group Id
- BG000
- value
- 450
- group Id
- BG001
- value
- 458
- group Id
- BG002
- value
- 908
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 111
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 489
- group Id
- BG001
- value
- 490
- group Id
- BG002
- value
- 979
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 85
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 457
- group Id
- BG001
- value
- 456
- group Id
- BG002
- value
- 913
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 81
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 94
- group Id
- BG001
- value
- 101
- group Id
- BG002
- value
- 195
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Singapore
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 36
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 9
- title
- Thailand
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- title
- Portugal
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 32
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 8
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 58
- title
- Brazil
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 47
- title
- Korea, Republic of
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 128
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 19
- title
- Slovakia
- categories
- measurements
- group Id
- BG000
- value
- 34
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 73
- title
- France
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 164
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 344
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 332
- group Id
- BG001
- value
- 320
- group Id
- BG002
- value
- 652
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 96
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 3
- description
- ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 44
- title
- Ex-Light Smoker
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 53
- title
- Non-Smoker
- categories
- measurements
- group Id
- BG000
- value
- 500
- group Id
- BG001
- value
- 495
- group Id
- BG002
- value
- 995
- title
- Smoker
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Missing
- param Type
- NUMBER
- title
- Smoking History
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Stage IIIB
- categories
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 546
- group Id
- BG002
- value
- 1089
- title
- Stage IV
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Missing
- description
- Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.
- param Type
- NUMBER
- title
- Disease Stage at Study Entry
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 545
- group Id
- BG002
- value
- 1088
- title
- Squamous
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Other Histology
- param Type
- NUMBER
- title
- Disease Histology
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 120
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 251
- title
- Bone
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 58
- title
- Brain
- categories
- measurements
- group Id
- BG000
- value
- 109
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 226
- title
- Liver
- categories
- measurements
- group Id
- BG000
- value
- 453
- group Id
- BG001
- value
- 453
- group Id
- BG002
- value
- 906
- title
- Lung
- categories
- measurements
- group Id
- BG000
- value
- 431
- group Id
- BG001
- value
- 451
- group Id
- BG002
- value
- 882
- title
- Lymph Nodes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 37
- title
- Peritoneal
- categories
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 304
- title
- Pleural
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 17
- title
- Skin
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 44
- title
- Soft Tissue
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 146
- group Id
- BG002
- value
- 302
- title
- Other
- description
- Participants may record multiple sites of metastatic disease.
- param Type
- NUMBER
- title
- Sites of Metastatic Disease
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 545
- group Id
- BG001
- value
- 548
- group Id
- BG002
- value
- 1093
- units
- Participants
- groups
- description
- Necitumumab + Gemcitabine + Cisplatin Necitumumab: 800 mg I.V. infusion on Days 1 and 8 of every 3 week cycle. Continues until progressive disease, toxicity, noncompliance, or withdrawal. Gemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle. Continues for a maximum of six cycles. Cisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle. Continues for a maximum of six cycles.
- id
- BG000
- title
- Necitumumab + Gemcitabine + Cisplatin
- description
- Gemcitabine + Cisplatin Gemcitabine: 1250 mg/m2 on Days 1 and 8 of every 3 week cycle. Continues for a maximum of six cycles. Cisplatin: 75 mg/m2 IV on Day 1 of every 3 week cycle. Continues for a maximum of six cycles.
- id
- BG001
- title
- Gemcitabine + Cisplatin
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 32
- upper Limit
- 84
- value
- 62.0
- group Id
- BG001
- lower Limit
- 32
- upper Limit
- 86
- value
- 62.0
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 86
- value
- 62.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 95
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 185
- title
- Female
- measurements
- group Id
- BG000
- value
- 450
- group Id
- BG001
- value
- 458
- group Id
- BG002
- value
- 908
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 111
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 489
- group Id
- BG001
- value
- 490
- group Id
- BG002
- value
- 979
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 85
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 11
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 457
- group Id
- BG001
- value
- 456
- group Id
- BG002
- value
- 913
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 81
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 94
- group Id
- BG001
- value
- 101
- group Id
- BG002
- value
- 195
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Singapore
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 36
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 9
- title
- Thailand
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 17
- title
- Portugal
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 32
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 8
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 58
- title
- Brazil
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 47
- title
- Korea, Republic of
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 128
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 19
- title
- Slovakia
- categories
- measurements
- group Id
- BG000
- value
- 34
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 73
- title
- France
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 164
- group Id
- BG001
- value
- 180
- group Id
- BG002
- value
- 344
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 332
- group Id
- BG001
- value
- 320
- group Id
- BG002
- value
- 652
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 96
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 3
- description
- ECOG classifies participants according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). 1 participant with ECOG PS 3 was randomized to the Gemcitabine + Cisplatin arm but did not receive treatment.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) at Baseline
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 44
- title
- Ex-Light Smoker
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 53
- title
- Non-Smoker
- categories
- measurements
- group Id
- BG000
- value
- 500
- group Id
- BG001
- value
- 495
- group Id
- BG002
- value
- 995
- title
- Smoker
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Missing
- param Type
- NUMBER
- title
- Smoking History
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Stage IIIB
- categories
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 546
- group Id
- BG002
- value
- 1089
- title
- Stage IV
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Missing
- description
- Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIB - the cancer has spread to nearby tissue or spread to far away lymph nodes. Stage IV - the cancer has spread to other organs of the body such as the other lung, brain, or liver.
- param Type
- NUMBER
- title
- Disease Stage at Study Entry
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 545
- group Id
- BG002
- value
- 1088
- title
- Squamous
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Other Histology
- param Type
- NUMBER
- title
- Disease Histology
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 120
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 251
- title
- Bone
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 58
- title
- Brain
- categories
- measurements
- group Id
- BG000
- value
- 109
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 226
- title
- Liver
- categories
- measurements
- group Id
- BG000
- value
- 453
- group Id
- BG001
- value
- 453
- group Id
- BG002
- value
- 906
- title
- Lung
- categories
- measurements
- group Id
- BG000
- value
- 431
- group Id
- BG001
- value
- 451
- group Id
- BG002
- value
- 882
- title
- Lymph Nodes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 37
- title
- Peritoneal
- categories
- measurements
- group Id
- BG000
- value
- 149
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 304
- title
- Pleural
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 17
- title
- Skin
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 44
- title
- Soft Tissue
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 146
- group Id
- BG002
- value
- 302
- title
- Other
- description
- Participants may record multiple sites of metastatic disease.
- param Type
- NUMBER
- title
- Sites of Metastatic Disease
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle